Graphdiyne oxide nanosheets reprogram immunosuppressive macrophage for cancer immunotherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Immune cells in cancer · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Morphologically virus-like fullerenol nanoparticles act as the dual-functional nanoadjuvant for HIV-1 vaccine10.1002/adma.201300583 ↗
2. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets10.1016/j.biomaterials.2014.08.033 ↗
3. The inhibition of death receptor mediated apoptosis through lysosome stabilization following internalization of carboxyfullerene nanoparticles10.1016/j.biomaterials.2011.02.008 ↗
4. Fullerene derivatives protect endothelial cells against NO-induced damage10.1088/0957-4484/20/22/225103 ↗
5. Direct synthesis of crystalline graphtetrayne—a new graphyne allotrope10.31635/ccschem.020.202000377 ↗
6. Chemical modification and functionalization of graphdiyne10.3866/PKU.WHXB201801302 ↗
7. Advanced progress in the synthesis of graphdiyne10.3866/PKU.WHXB201801243 ↗
8. Comparisons between graphene oxide and graphdiyne oxide in physicochemistry biology and cytotoxicity10.1021/acsami.8b06804 ↗
9. Graphdiyne oxide and graphene oxide sense monovalent cations differently: the alkyne and alkene physicochemistry10.1016/j.nantod.2021.101141 ↗
10. Tumor reoxygenation and blood perfusion enhanced photodynamic therapy using ultrathin graphdiyne oxide nanosheets10.1021/acs.nanolett.9b01458 ↗
11. Graphdiyne nanosheet-based drug delivery platform for photothermal/chemotherapy combination treatment of cancer10.1021/acsami.7b17219 ↗
12. Immobilized ferrous ion and glucose oxidase on graphdiyne and its application on one-step glucose detection10.1021/acsami.8b03118 ↗
13. Graphdiyne-templated palladium-nanoparticle assembly as a robust oxygen generator to attenuate tumor hypoxia10.1016/j.nantod.2020.100907 ↗
14. Graphdiyne: structure of fluorescent quantum dots10.1002/anie.202006891 ↗
15. Synthesis and imaging of biocompatible graphdiyne quantum dots10.1021/acsami.9b12801 ↗
16. The underlying function and structural organization of the intracellular protein corona on graphdiyne oxide nanosheet for local immunomodulation10.1021/acs.nanolett.1c01048 ↗
17. Biodegradation of graphdiyne oxide in classically activated (M1) macrophages modulates cytokine production10.1039/D1NR02473F ↗
18. 2D Graphdiyne oxide serves as a superior new generation of antibacterial agents10.1016/j.isci.2019.08.019 ↗
19. Graphdiyne: synthesis, properties, and applications10.1039/C8CS00773J ↗
20. Multifunctional graphdiyne-cerium oxide nanozymes facilitate microRNA delivery and attenuate tumor hypoxia for highly efficient radiotherapy of esophageal cancer
21. Immunosuppressive networks in the tumour environment and their therapeutic relevance10.1038/nrc1586 ↗
22. Biomaterial-assisted targeted modulation of immune cells in cancer treatment10.1038/s41563-018-0147-9 ↗
23. In situ phase transitional polymeric vaccines for improved immunotherapy10.1093/nsr/nwab159 ↗
24. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery10.1038/nrd4333 ↗
25. Use of nanoformulation to target macrophages for disease treatment
26. Targeting macrophages: therapeutic approaches in cancer10.1038/nrd.2018.169 ↗
27. Carbon-based nanomaterials for cancer therapy via targeting tumor microenvironment10.1002/adhm.201800525 ↗
28. Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells10.1016/j.nano.2011.08.019 ↗
29. Targeting macrophages in cancer: from bench to bedside10.3389/fonc.2018.00049 ↗
30. Progress in tumor-associated macrophages: from bench to bedside
31. Macrophage diversity enhances tumor progression and metastasis10.1016/j.cell.2010.03.014 ↗
32. Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies10.1093/nsr/nwaa099 ↗
33. Macrophage polarization10.1146/annurev-physiol-022516-034339 ↗
34. Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer10.1038/s41467-021-24564-0 ↗
35. Targeting tumor associated macrophages: the new challenge for nanomedicine10.1016/j.smim.2017.09.004 ↗
36. Tailoring nanomaterials for targeting tumor-associated macrophages10.1002/adma.201808303 ↗
37. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype10.1016/j.it.2011.03.007 ↗
38. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues10.1038/nnano.2016.168 ↗
39. Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation10.1016/j.apsb.2017.09.005 ↗
40. Exploration of zinc oxide nanoparticles as a multitarget and multifunctional anticancer nanomedicine10.1021/acsami.7b11219 ↗
41. Functional gadofullerene nanoparticles trigger robust cancer immunotherapy based on rebuilding an immunosuppressive tumor microenvironment10.1021/acs.nanolett.0c01287 ↗
42. Gd-metallofullerenol drug delivery system mediated macrophage polarization enhances the efficiency of chemotherapy10.1016/j.jconrel.2020.01.053 ↗
43. Polyhydroxylated metallofullerenols stimulate IL-1β secretion of macrophage through TLRs/MyD88/NF-κB pathway and NLRP3 inflammasome activation10.1002/smll.201302825 ↗
44. Polymer nanoparticles regulate macrophage repolarization for antitumor treatment10.1039/D1CC02678J ↗
45. Quantum dot-pulsed dendritic cell vaccines plus macrophage polarization for amplified cancer immunotherapy10.1016/j.biomaterials.2020.119928 ↗
46. Crucial role of lateral size for graphene oxide in activating macrophages and stimulating pro-inflammatory responses in cells and animals10.1021/acsnano.5b04751 ↗
47. Targeting tumor associated macrophages (TAMs) via nanocarriers10.1016/j.jconrel.2017.03.395 ↗
48. Architecture of graphdiyne nanoscale films10.1039/b922733d ↗
49. Graphdiyne: from preparation to biomedical applications10.1007/s40242-021-1343-8 ↗
50. NF-kappaB signaling in inflammation and cancer10.1002/mco2.104 ↗
51. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy10.1016/j.biomaterials.2019.119559 ↗
52. Activating a collaborative innate-adaptive immune response to control metastasis
53. A STAT3-based gene signature stratifies glioma patients for targeted therapy10.1038/s41467-019-11614-x ↗
54. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD3910.1038/s41593-019-0370-y ↗